Patents Assigned to Nervive, Inc.
  • Patent number: 10589086
    Abstract: An apparatus for providing deep nerve stimulation to a patient includes a housing for supporting deep nerve stimulation coils. The housing includes a wall with an outer surface for being presented toward the patient to apply the stimulation. A primary coil is supported in a primary chamber of the housing adjacent an inner surface of the wall, opposite the outer surface. Ribs are disposed between the primary coil and the inner surface and upon which the primary coil rests. The ribs define channels through which coolant can be directed to cool a bottom surface of the primary coil during use, the bottom surface of the primary coil being closest to the patient side wall. The primary coil is adapted when energized to produce a broad and deeply penetrating magnetic field capable of hitting a target area of the patient.
    Type: Grant
    Filed: October 2, 2015
    Date of Patent: March 17, 2020
    Assignee: NERVIVE, INC
    Inventors: Emilio Sacristan, Douglas Stewart Szumski, Jonathan Velleuer, Judith Müller, Mark Borsody
  • Patent number: 10105549
    Abstract: Stimulation of the facial nerve system (e.g., electrically, electromagnetically, etc.) in ischemic stroke patients will cause dilation of occluded arteries and dilation of surrounding arteries, allowing for blood flow to circumvent the obstruction and reach previously-deprived tissue. The device approaches the facial nerve and its branches in the vicinity of the ear. In use, the device can be inserted into the ear canal and/or placed in proximity to the ear in order to stimulate the facial nerve system non-invasively (e.g., using an electromagnetic field). The device can be used in the emergency treatment of acute stroke or chronically variations for long-term maintenance of blood flow to the brain and stroke prevention. Additional embodiments of the device may be adapted for use on different regions of the body.
    Type: Grant
    Filed: February 29, 2016
    Date of Patent: October 23, 2018
    Assignee: Nervive, Inc.
    Inventor: Mark Klingler Borsody
  • Patent number: 10065047
    Abstract: Herein is described a device and methods-of-use to treat multiple possible causes of sudden neurological dysfunction related to cardiac, cerebrovascular, or brain electrical abnormalities. The device can be employed so as to treat cardiac dysfunction such as arrhythmia and subsequently related dysfunction of the central nervous system such as stroke and seizure. Alternatively, the device can be employed so as to treat cardiac dysfunction simultaneous with treatment of dysfunction of the central nervous system. Finally, the device can be employed so as to augment the effectiveness of treating cardiac dysfunction, namely the restoration of cardiac output and blood flow to the brain, by dilating the arteries of the brain.
    Type: Grant
    Filed: May 20, 2014
    Date of Patent: September 4, 2018
    Assignee: Nervive, Inc.
    Inventor: Mark Klingler Borsody
  • Patent number: 9339645
    Abstract: Stimulation of the facial nerve system (e.g., electrically, electromagnetically, etc.) in stroke patients will cause dilation of occluded arteries and dilation of surrounding arteries, allowing for blood flow to circumvent the obstruction and reach previously-deprived tissue. The device approaches the facial nerve and its branches in the vicinity of the ear. In use, the device can be inserted into the ear canal or placed in proximity to the ear in order to stimulate the facial nerve system without puncturing the tympanic membrane (e.g., using an electromagnetic field). The device can also be advanced into the middle ear through a puncture created in the tympanic membrane. Branches of the facial nerve in the middle ear can then be stimulated directly (e.g., by application of electrical current). The device can be used in the emergency treatment of acute stroke or as chronically-implanted/inserted variations for long-term maintenance of blood flow to the brain and stroke prevention.
    Type: Grant
    Filed: April 28, 2011
    Date of Patent: May 17, 2016
    Assignee: Nervive, Inc.
    Inventor: Mark Klingler Borsody
  • Patent number: 9272157
    Abstract: Stimulation of the facial nerve system (e.g., electrically, electromagnetically, etc.) in ischemic stroke patients will cause dilation of occluded arteries and dilation of surrounding arteries, allowing for blood flow to circumvent the obstruction and reach previously-deprived tissue. The device approaches the facial nerve and its branches in the vicinity of the ear. In use, the device can be inserted into the ear canal and/or placed in proximity to the ear in order to stimulate the facial nerve system non-invasively (e.g., using an electromagnetic field). The device can be used in the emergency treatment of acute stroke or chronically variations for long-term maintenance of blood flow to the brain and stroke prevention. Additional embodiments of the device may be adapted for use on different regions of the body.
    Type: Grant
    Filed: December 3, 2012
    Date of Patent: March 1, 2016
    Assignee: Nervive, Inc.
    Inventor: Mark Klingler Borsody